Skip to main content

Table 1 Clinical characteristics of Mexican children with hemophilia treated with Radiosynoviorthesis with Yttrium(90) citrate

From: Treatment with radiosynoviorthesis in hemophilic patients with and without inhibitor

Patient IDType of hemophiliaGradeInhibitorAge (in years) at the time of the first RS with C-Y(90)Average of bleeding events per year before treatment with C-Y(90)Average of bleeding events per year after treatment with C-Y(90)Joint treated with RS (1st application)Pettersson scoreJoint treated with RS (2nd application)Pettersson scoreJoint treated with RS (3rd application)Pettersson scoreJoint treated with RS (4th application)Pettersson score
1AModerateNo1080–1Ankle8Elbow8    
2ASevereNo15110–1Knee/Ankle8/3Knee8    
3AMildNo1030–1Knee3      
4ASevereNo14100–1Knee8      
5ASevereNo10120–1Knee3Knee/Ankle8/8    
6BSevereNo14200–1Knee3Knee3    
7AModerateNo1470–1Ankle/Elbow3/8Knee8Knee3Knee3
8ASevereYes33610Knee1Ankle3Knee8Knee8
9ASevereYes11180–1Knee3      
10ASevereYes8160–1Ankle8      
11ASevereNo15113Knee3Knee8Knee3  
12ASevereYes11300–1Ankle8Ankle8    
13ASevereYes14180–1Ankle8Ankle3Knee8  
14ASevereNo11100–1Ankle8Ankle8    
15BModerateNo9110–1Ankle/Elbow3/1Ankle3    
16ASevereNo14110–1Ankle3Ankle3    
17AModerateNo960–1Knee/Ankle3/3      
18AModerateNo1360–1Knee3      
19ASevereNo15120–1Elbow8      
20ASevereNo13120–1Ankle/Elbow3/8Elbow3    
21AModerateNo1670–1Knee8      
22AModerateNo1480–1Knee8      
23ASevereYes13150–1Knee8Knee3    
24BSevereNo9180–1Knee/Elbow8/8      
25ASevereNo13120–1Elbow/Knee/Ankle3/3/3Ankle3    
26ASevereNo9110–1Ankle/Elbow3/8      
27ASevereNo15103Elbow3Knee8Knee8  
RS C-Y(90) Radiosynoviorthesis with Yttrium(90) citrate